The correlation analysis between the expression levels of CD86, CD206, and PD-L1 in cancer tissues of 60 patients with HCC and the clinicopathological features indicated the correlation of the expression of PD-L1 with the degree of tumor differentiation (χ2 = 7.855, P = 0.02). The gene discussed is CD86; the disease is hepatocellular carcinoma.